Granulocyte-colony stimulating factor and umbilical cord blood cell transplantation: Synergistic therapies for the treatment of traumatic brain injury

Traumatic brain injury (TBI) is now characterized as a progressive, degenerative disease and continues to stand as a prevalent cause of death and disability. The pathophysiology of TBI is complex, with a variety of secondary cell death pathways occurring which may persist chronically following the i...

Full description

Bibliographic Details
Main Authors: Michael G Liska, Ike dela Peña
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2017-01-01
Series:Brain Circulation
Subjects:
Online Access:http://www.braincirculation.org/article.asp?issn=2394-8108;year=2017;volume=3;issue=3;spage=143;epage=151;aulast=Liska
id doaj-52131c084cc74ff6b4f4d7d736cc72b8
record_format Article
spelling doaj-52131c084cc74ff6b4f4d7d736cc72b82020-11-24T21:34:33ZengWolters Kluwer Medknow PublicationsBrain Circulation2394-81082455-46262017-01-013314315110.4103/bc.bc_19_17Granulocyte-colony stimulating factor and umbilical cord blood cell transplantation: Synergistic therapies for the treatment of traumatic brain injuryMichael G LiskaIke dela PeñaTraumatic brain injury (TBI) is now characterized as a progressive, degenerative disease and continues to stand as a prevalent cause of death and disability. The pathophysiology of TBI is complex, with a variety of secondary cell death pathways occurring which may persist chronically following the initial cerebral insult. Current therapeutic options for TBI are minimal, with surgical intervention or rehabilitation therapy existing as the only viable treatments. Considering the success of stem-cell therapies in various other neurological diseases, their use has been proposed as a potential potent therapy for patients suffering TBI. Moreover, stem cells are highly amenable to adjunctive use with other therapies, providing an opportunity to overcome the inherent limitations of using a single therapeutic agent. Our research has verified this additive potential by demonstrating the efficacy of co-delivering human umbilical cord blood (hUCB) cells with granulocyte-colony stimulating factor (G-CSF) in a murine model of TBI, providing encouraging results which support the potential of this approach to treat patients suffering from TBI. These findings justify ongoing research toward uncovering the mechanisms which underlie the functional improvements exhibited by hUCB + G-CSF combination therapy, thereby facilitating its safe and effect transition into the clinic. This paper is a review article. Referred literature in this paper has been listed in the reference section. The datasets supporting the conclusions of this article are available online by searching various databases, including PubMed. Some original points in this article come from the laboratory practice in our research center and the authors' experiences.http://www.braincirculation.org/article.asp?issn=2394-8108;year=2017;volume=3;issue=3;spage=143;epage=151;aulast=LiskaCentral nervous system disordersgranulocyte-colony stimulating factorhuman umbilical cord bloodregenerative medicinestem-cell therapytraumatic brain injury
collection DOAJ
language English
format Article
sources DOAJ
author Michael G Liska
Ike dela Peña
spellingShingle Michael G Liska
Ike dela Peña
Granulocyte-colony stimulating factor and umbilical cord blood cell transplantation: Synergistic therapies for the treatment of traumatic brain injury
Brain Circulation
Central nervous system disorders
granulocyte-colony stimulating factor
human umbilical cord blood
regenerative medicine
stem-cell therapy
traumatic brain injury
author_facet Michael G Liska
Ike dela Peña
author_sort Michael G Liska
title Granulocyte-colony stimulating factor and umbilical cord blood cell transplantation: Synergistic therapies for the treatment of traumatic brain injury
title_short Granulocyte-colony stimulating factor and umbilical cord blood cell transplantation: Synergistic therapies for the treatment of traumatic brain injury
title_full Granulocyte-colony stimulating factor and umbilical cord blood cell transplantation: Synergistic therapies for the treatment of traumatic brain injury
title_fullStr Granulocyte-colony stimulating factor and umbilical cord blood cell transplantation: Synergistic therapies for the treatment of traumatic brain injury
title_full_unstemmed Granulocyte-colony stimulating factor and umbilical cord blood cell transplantation: Synergistic therapies for the treatment of traumatic brain injury
title_sort granulocyte-colony stimulating factor and umbilical cord blood cell transplantation: synergistic therapies for the treatment of traumatic brain injury
publisher Wolters Kluwer Medknow Publications
series Brain Circulation
issn 2394-8108
2455-4626
publishDate 2017-01-01
description Traumatic brain injury (TBI) is now characterized as a progressive, degenerative disease and continues to stand as a prevalent cause of death and disability. The pathophysiology of TBI is complex, with a variety of secondary cell death pathways occurring which may persist chronically following the initial cerebral insult. Current therapeutic options for TBI are minimal, with surgical intervention or rehabilitation therapy existing as the only viable treatments. Considering the success of stem-cell therapies in various other neurological diseases, their use has been proposed as a potential potent therapy for patients suffering TBI. Moreover, stem cells are highly amenable to adjunctive use with other therapies, providing an opportunity to overcome the inherent limitations of using a single therapeutic agent. Our research has verified this additive potential by demonstrating the efficacy of co-delivering human umbilical cord blood (hUCB) cells with granulocyte-colony stimulating factor (G-CSF) in a murine model of TBI, providing encouraging results which support the potential of this approach to treat patients suffering from TBI. These findings justify ongoing research toward uncovering the mechanisms which underlie the functional improvements exhibited by hUCB + G-CSF combination therapy, thereby facilitating its safe and effect transition into the clinic. This paper is a review article. Referred literature in this paper has been listed in the reference section. The datasets supporting the conclusions of this article are available online by searching various databases, including PubMed. Some original points in this article come from the laboratory practice in our research center and the authors' experiences.
topic Central nervous system disorders
granulocyte-colony stimulating factor
human umbilical cord blood
regenerative medicine
stem-cell therapy
traumatic brain injury
url http://www.braincirculation.org/article.asp?issn=2394-8108;year=2017;volume=3;issue=3;spage=143;epage=151;aulast=Liska
work_keys_str_mv AT michaelgliska granulocytecolonystimulatingfactorandumbilicalcordbloodcelltransplantationsynergistictherapiesforthetreatmentoftraumaticbraininjury
AT ikedelapena granulocytecolonystimulatingfactorandumbilicalcordbloodcelltransplantationsynergistictherapiesforthetreatmentoftraumaticbraininjury
_version_ 1725948901273370624